Develops DL Precise™, an FDA-cleared medical imaging software that uses real-time lesion-level segmentation and color contrast to improve visualization of dense breast tissue in mammograms, ultrasounds, MRIs, CTs, and X-rays. This technology reduces missed cancer diagnoses, minimizes unnecessary follow-up procedures, and increases radiology workflow efficiency by enabling precise assessment and side-by-side comparison of prior images. By integrating seamlessly into existing platforms, it enhances diagnostic accuracy without requiring additional tools or certifications.
Funding
Funding not disclosed
Founders
Product
Problem
Mammogram analysis can be challenging due to the nuances of dense breast tissue, leading to a significant percentage of cancers being missed with existing imaging solutions. Human eyes can only perceive a limited range of gray shades on medical imaging monitors, further complicating the detection of subtle lesions. This can result in delayed diagnoses and increased callbacks for additional screenings.
Solution
DeepLook Medical's DL Precise™ technology addresses the challenges of dense breast tissue imaging by enhancing lesion visualization through real-time segmentation and color contrast. The FDA-cleared software integrates directly into existing radiology workflows, operating within partner platforms to focus on regions of interest without requiring additional tools or certifications. By unlocking the complete spectrum of imaging shades, DL Precise™ highlights suspicious dense masses, enabling radiologists to focus on critical cases with improved speed and clarity. This leads to more efficient workflows, reduced unnecessary diagnostics, and higher throughput for radiology centers.
Target Audience
The primary target audience includes radiologists, radiology centers, and healthcare providers seeking to improve diagnostic accuracy and efficiency in breast cancer screening, particularly in cases involving dense breast tissue.
Features
- Real-time lesion segmentation and measurement, visualizing lesions in color for precise assessment.
- Side-by-side comparison of prior images for improved assessment of changes over time.
- On-demand embedded workflow integration, operating within existing platforms without additional screens or certifications.
- Multi-modal support, compatible with mammography, ultrasounds, MRIs, CTs, and X-rays.
- AI-driven analysis to improve early detection of interval cancers.
- Integration with top healthcare institutions across the US.